|
|
|
Springworks Therapeutics Inc (NASDAQ: SWTX) |
|
Springworks Therapeutics Inc
SWTX's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Springworks Therapeutics Inc 's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 13.29 %
• More on SWTX's Growth
|
|
Springworks Therapeutics Inc
realized a net loss in trailing twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.44.
• More on SWTX's Valuation
|
|
|
|
|
Springworks Therapeutics Inc
realized net loss in trailing twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.44.
| | | |
